SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17064981
Source:
http://linkedlifedata.com/resource/pubmed/id/17064981
Search
Subject
(
35
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007600
,
umls-concept:C0079419
,
umls-concept:C0205396
,
umls-concept:C0596611
,
umls-concept:C0883208
,
umls-concept:C1333064
pubmed:issue
9
pubmed:dateCreated
2006-10-26
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17064981-17065008
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007422
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1042-8194
pubmed:author
pubmed-author:MakiCarl GCG
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1734-5
pubmed:meshHeading
pubmed-meshheading:17064981-Exons
,
pubmed-meshheading:17064981-Gene Expression Regulation, Neoplastic
,
pubmed-meshheading:17064981-Hodgkin Disease
,
pubmed-meshheading:17064981-Humans
,
pubmed-meshheading:17064981-Mutation
,
pubmed-meshheading:17064981-Sequence Deletion
,
pubmed-meshheading:17064981-Tumor Suppressor Protein p53
pubmed:year
2006
pubmed:articleTitle
P53 gene alterations identified in classical Hodgkin's lymphoma cell lines.
pubmed:affiliation
Department of Radiation and Cellular Oncology, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA. cmaki@rover.uchicago.edu
pubmed:publicationType
Editorial
,
Comment